share_log

Mineralys Therapeutics Q1 2024 GAAP EPS $(0.70) Misses $(0.67) Estimate

Benzinga ·  May 9 07:16

Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.67) by 4.48 percent. This is a 37.25 percent decrease over losses of $(0.51) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment